FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the use of an artemisinin derivative SM934 or a pharmaceutically acceptable salt thereof for preparation of a medicament for inhibiting the infiltration of inflammatory cells into the colon tissue and down-regulation of the level of pro-inflammatory cytokines in the colon tissues.
EFFECT: inhibition of inflammatory cell infiltration into colon tissue; and downregulation of proinflammatory cytokine levels in colon tissue by compound SM934.
1 cl, 1 tbl, 7 dwg
SM934
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PRODUCTS BASED ON LANTHIONINE SYNTHETASE C-LIKE 2 PROTEIN | 2020 |
|
RU2768888C1 |
| INDENE DERIVATIVES APPLICABLE IN TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2012 |
|
RU2601307C2 |
| MEDICINES BASED ON LANTIONINE SYNTHETASE OF C-LIKE PROTEIN 2 | 2015 |
|
RU2741576C2 |
| DRUG PREPARATIONS BASED ON LANTHIONINE SYNTHETASE OF C-LIKE PROTEIN | 2015 |
|
RU2688677C2 |
| LACTOBACILLUS PARACASEI STRAIN AND ITS USE | 2019 |
|
RU2790297C2 |
| STRAIN LACTOBACILLUS GASSERI KBL697 AND ITS USE | 2019 |
|
RU2798872C2 |
| THERAPEUTIC MEDICATION FOR INFLAMMATORY INTESTINAL DISEASES WHICH CONTAINS DERIVATIVE OF 2-AMINO-1,3-PROPANDIOL AS ACTIVE INGREDIENT, OR METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2007 |
|
RU2428976C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ATTENUATED Streptococcus pneumoniae STRAINS, AND ITS APPLICATION | 2018 |
|
RU2772131C2 |
| NEW EP4 AGONIST | 2011 |
|
RU2564414C2 |
| ANTISENSE OLIGONUCLEOTIDES (ODN) TO Smad7 AND THEIR APPLICATION IN FIELD OF MEDICINE | 2004 |
|
RU2339697C2 |
